Claims for Patent: 10,028,480

Summary for Patent: 10,028,480

Title:	Ganoderma lucidum strain suitable for large-scale liquid fermentation culture, method of mutation breeding the same, and use of the strain
Abstract:	Disclosed is a Ganoderma Lucidum strain suitable for large-scale liquid fermentation, named as Ganoderma Lucidum G2, deposited with China General Microbiological Culture Collection Center under the accession number CGMCC No. 3982 on Jul. 20, 2010, and a method of mutation breeding the same and use of the strain. The Ganoderma Lucidum strain which belongs to Ganodermataceae, genus Ganoderma, species red Ganoderma Lucidum is obtained by artificial mutagenizing and breeding. The production of mycelia using the Ganoderma Lucidum strain G2 is 80.about.120 times higher as compared with the production of mycelia using wild-type naive Ganoderma Lucidum strain. The mycelia produced using the Ganoderma Lucidum strain G2 have higher contents of main pharmaceutical ingredients. The Ganoderma Lucidum strain suitable for large-scale liquid fermentation can be used for manufacturing oral solution or beverage comprising Ganoderma mycelia or extracts of Ganoderma mycelia as main active ingredient.
Inventor(s):	Zhou; Yingkui (Kunming, CN), Zhou; Meng (Kunming, CN), Zhou; Nuo (Kunming, CN)
Assignee:	Yunnan Mingshida-Science-Tech Co., Ltd. (Kunming, CN)
Application Number:	15/057,441
Patent Claims:	1. A method of obtaining a Ganoderma lucidum strain by mutagenizing and breeding, comprising the steps of (a) subjecting pileus and stipe of non-lignified wild Ganoderma fruiting body to protoplast isolation, inoculating the isolate into a basic medium for culturing for 10.about.20 days, and subjecting the resultant Ganoderma mycelia to repeated isolation and purification, thereby obtaining wild-type naive Ganoderma mycelia; (b) inoculating the wild-type naive Ganoderma mycelia from step (1) into a basic medium for culturing, then into a fermentation broth for culturing in a shaker, thereby obtaining a suspension of the wild-type naive Ganoderma mycelia; and (c) subjecting the wild-type naive Ganoderma mycelia from step (2) to a combinatory mutagenizing and breeding process of UV radiation, NaN.sub.3 chemical mutagenesis and transient heating in sterile water at 80.degree. C..about.90.degree. C., thereby obtaining a Ganoderma lucidum strain suitable for efficient production of Ganoderma mycelia in large-scale liquid fermentation. 2. The method of claim 1, wherein the basic medium used in step (a) for the protoplast isolation and purification of pileus and stipe of non-lignified wild Ganoderma fruiting body has the following composition: TABLE-US-00010 (NH.sub.4).sub.2HPO.sub.4 0.3 g KH.sub.2PO.sub.4 0.2 g MgSO.sub.4.cndot.7H.sub.2O 0.02 g NaCl 0.5 g FeSO.sub.4.cndot.7H.sub.2O 0.03 g sucrose 20 g sterile water 1000 ml. 3. The method of claim 1, wherein the basic medium in step (b) has the following composition: TABLE-US-00011 (NH.sub.4).sub.2HPO.sub.4 0.6 g KH.sub.2PO.sub.4 0.5 g MgSO.sub.4.cndot.7H.sub.2O 0.05 g NaCl 0.5 g FeSO.sub.4.cndot.7H.sub.2O 0.03 g sucrose 30 g peptone 3 g sterile water 1000 ml. 4. The method of claim 1, wherein the fermentation broth in step (b) has the following composition: TABLE-US-00012 (NH.sub.4).sub.2HPO.sub.4 0.8 g KH.sub.2PO.sub.4 0.5 g MgSO.sub.4.cndot.7H.sub.2O 0.05 g NaCl 1 g FeSO.sub.4.cndot.7H.sub.2O 0.03 g sucrose 25 g maltose 5 g peptone 3 g silkworm chrysalis meal 2 g sterile water 1000 ml; with the following fermentation condition: optimal culture temperature: 32.+-.1.degree. C., content of dissolved oxygen: 0.05 mmol/L.about.0.20 mmol/L, and pH: 4.5.about.5.5. 5. The method of claim 1, wherein the UV radiation in step (c) comprises irradiating the wild-type naive Ganoderma mycelia with a 40 W UV lamp from a distance of 20 cm for 5-20 min; the NaN.sub.3 chemical mutagenesis comprises preparing a chemical mutagenesis agent by dissolving 1 g of NaN.sub.3 of 1.2 equivalent into a mixture of 5 ml of dimethylformamide (DMF) and 5 ml of dimethyl sulfoxide (DMSO), and adding the wild-type naive Ganoderma mycelia after UV radiation into the chemical mutagenesis agent for chemical mutagenesis treatment of 5-20min; and the transient heating in sterile water comprises washing the wild-type naive Ganoderma mycelia after chemical mutagenesis with sterile water, followed by transient heating in sterile water at 80.degree. C..about.90.degree. C. for 1.about.10 sec. 6. The method of claim 5, wherein in step (c), the radiation duration is 10 min in the UV radiation; and/or the mutagenesis treatment duration is 20 min in NaN.sub.3 chemical mutagenesis; and/or in the transient heating in sterile water, sterile water at 85.degree. C. is used and the heating duration is 10 sec. 7. The method of claim 1, wherein in step (a), the non-lignified wild Ganoderma fruiting body is collected from Prunus mume. 8. The method of claim 2, wherein in step (a), the non-lignified wild Ganoderma fruiting body is collected from Prunus mume. 9. The method of claim 3, wherein in step (a), the non-lignified wild Ganoderma fruiting body is collected from Prunus mume. 10. The method of claim 4, wherein in step (a), the non-lignified wild Ganoderma fruiting body is collected from Prunus mume. 11. The method of claim 5, wherein in step (a), the non-lignified wild Ganoderma fruiting body is collected from Prunus mume. 12. The method of claim 6, wherein in step (a), the non-lignified wild Ganoderma fruiting body is collected from Prunus mume.

Details for Patent 10,028,480

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2035-03-18